跳至主要内容
临床试验/NCT00190853
NCT00190853已完成3 期

Effect of Duloxetine on Valsalva Leak Point Pressure and Quantitative Rhabdosphincter Electromyography Measures in Women With Stress Urinary Incontinence

Eli Lilly and Company19 个研究点 分布在 3 个国家目标入组 93 人开始时间: 2005年1月最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
93
试验地点
19
主要终点
Assess the effects of duloxetine in women with urodynamically proved stress urinary incontinence on the within-group change in vesical Valsalva leak point pressure (VLPP) from baseline to endpoint.

研究概览

简要总结

Biomechanical and electrophysiological effects of duloxetine in the treatment of women with urinary stress incontinence

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Have a diagnosis of only stress urinary incontinence
  • Have no pelvic organ prolapse protruding more than 1 cm beyond the hymen

排除标准

  • At visit 1, have a positive urine culture or a history of four or more urinary tract infections in the preceding year.
  • Have had more than one continence surgery.
  • Have a current or past urogenital cancer.

结局指标

主要结局

Assess the effects of duloxetine in women with urodynamically proved stress urinary incontinence on the within-group change in vesical Valsalva leak point pressure (VLPP) from baseline to endpoint.

次要结局

  • To evaluate the within-group changes in VLPP and ratios of EMG variables from baseline to 6 months and from 4 weeks to 6 months.
  • To describe the percent change in incontinence episode frequency (IEF) from baseline to post-baseline and define two groups, responders and non-responders, based on threshold value of < 50% IEF reduction values.
  • To compare the changes in VLPP and EMG ratios from baseline to 4 weeks and from baseline to 6 months in responder and non responders
  • To evaluate the safety and tolerability of duloxetine for up to 28 weeks in subjects diagnosed with urodynamic stress incontinence.Based on treatment-emergent adverse events, discontinuation rates, vital signs, and laboratory analyses
  • To evaluate the within-group endpoint/baseline ratios of Root Mean Square Voltage and Mean Rectified Voltage from the rhabdosphincter electromyogram (EMG) at rest and with coughing, and the ratio of cough/rest ratios from baseline to endpoint.

研究者

申办方类型
Industry

研究点 (19)

Loading locations...

相似试验

Biomechanical and Electrophysiological Effects of... | 临床试验